MRI Assessment of Basal Ganglia Iron Deposition in Parkinson's Disease

被引:137
作者
Wallis, Lauren I. [1 ]
Paley, Marlyn N. J. [1 ]
Graham, Jacqueline M. [1 ]
Gruenewald, Richard A. [2 ]
Wignall, Emma L. [1 ]
Joy, Harriet M. [3 ]
Griffiths, Paul D. [1 ]
机构
[1] Univ Sheffield, Acad Unit Radiol, Sheffield, S Yorkshire, England
[2] Royal Hallamshire Hosp, Dept Clin Neurol, Sheffield S10 2JF, S Yorkshire, England
[3] Southampton Gen Hosp, Wessex Neurol Ctr, Southampton, Hants, England
关键词
magnetic resonance imaging; Parkinson's disease; brain iron; 3.0; Tesla;
D O I
10.1002/jmri.21563
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
Purpose: To estimate the levels of basal ganglia iron levels in Parkinson's disease (PD) using the PRIME MR sequence at 3.0 Tesla, in relation to patients' motor symptom severity. Materials and Methods: Seventy patients with PD and 10 healthy controls underwent assessment of movement and MR imaging. Mean R(2)' relaxation rates were recorded in the substantia nigra, frontal white matter and In the rostral, mid, and caudal putamen. Results: R(2)' relaxation rates were significantly higher in patients with PD than in healthy controls. R(2)' in the most affected substantia nigra correlated with PD patients' motor symptom severity, but not with disease duration. Neuroradiological observation revealed a rostral to caudal "gradient" of putaminal hypointensity. This was substantiated by the finding that the mid and caudal putamen showed significantly higher R(2)' relaxation rates, consistent with higher iron levels in PD relative to the healthy controls. Conclusion: MRI at 3.0 Tesla suggests that substantia nigra iron levels are increased and linked to the severity of motor symptoms experienced in PD. Findings consistent with increased iron levels in the PD putamen are shown, in a region-specific rostral to caudal gradient.
引用
收藏
页码:1061 / 1067
页数:7
相关论文
共 34 条
[1]
T2 RELAXATION-TIME IN PATIENTS WITH PARKINSONS-DISEASE [J].
ANTONINI, A ;
LEENDERS, KL ;
MEIER, D ;
OERTEL, WH ;
BOESIGER, P ;
ANLIKER, M .
NEUROLOGY, 1993, 43 (04) :697-700
[2]
Atasoy HT, 2004, NEUROL INDIA, V52, P332
[3]
Free radicals and aging [J].
Barja, G .
TRENDS IN NEUROSCIENCES, 2004, 27 (10) :595-600
[4]
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration [J].
Bartzokis, George ;
Tishler, Todd A. ;
Lu, Po H. ;
Villablanca, Pablo ;
Altshuler, Lori L. ;
Carter, Michele ;
Huang, Danny ;
Edwards, Nancy ;
Mintz, Jim .
NEUROBIOLOGY OF AGING, 2007, 28 (03) :414-423
[5]
Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease - A diagnostic algorithm [J].
Bhattacharya, K ;
Saadia, D ;
Eisenkraft, B ;
Yahr, M ;
Olanow, W ;
Drayer, B ;
Kaufmann, H .
ARCHIVES OF NEUROLOGY, 2002, 59 (05) :835-842
[6]
DOES SIGNAL-ATTENUATION ON HIGH-FIELD T2-WEIGHTED MRI OF THE BRAIN REFLECT REGIONAL CEREBRAL IRON DEPOSITION - OBSERVATIONS ON THE RELATIONSHIP BETWEEN REGIONAL CEREBRAL WATER PROTON T2 VALUES AND IRON LEVELS [J].
BROOKS, DJ ;
LUTHERT, P ;
GADIAN, D ;
MARSDEN, CD .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (01) :108-111
[7]
CHEN JC, 1993, AM J NEURORADIOL, V14, P275
[8]
Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease [J].
Clarke, CE .
LANCET NEUROLOGY, 2004, 3 (08) :466-474
[9]
Daniel S E, 1993, J Neural Transm Suppl, V39, P165
[10]
DEXTER DT, 1987, LANCET, V2, P1219